SCHEMBL3514262

SCHEMBL3514262

CCCCC(=O)ON(CCCC)C(C)=O

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 1/20 0.40
CES1 P23141 2/20 0.39
DGKA P23743 1/20 0.38
CES2 O00748 1/20 0.38
ALDH1A1 P00352 3/20 0.38
LMNA P02545 2/20 0.36
TP53 P04637 1/20 0.35
CA1 P00915 3/20 0.35
CA12 O43570 2/20 0.35
CA9 Q16790 2/20 0.35
PAM P19021 2/20 0.35
MAPT P10636 1/20 0.34
MAPK1 P28482 1/20 0.34
TSHR P16473 1/20 0.33
MMP1 P03956 1/20 0.33
MMP2 P08253 1/20 0.33
MMP3 P08254 1/20 0.33
MMP8 P22894 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16295067 0.86 NAAA (0.39) DNM1CES1DGKACES2ALDH1A1
SCHEMBL28335631 0.81 DNM1 (0.41) DNM1CES1DGKACES2ALDH1A1
SCHEMBL11111060 0.79 TSHR (0.44) DNM1CES1DGKACES2ALDH1A1
SCHEMBL28214910 0.78 CES1 (0.43) DNM1CES1DGKACES2ALDH1A1
SCHEMBL7916190 0.76 ALDH1A1 (0.40) DNM1CES1CES2ALDH1A1CA1
SCHEMBL18665383 0.75 CA1 (0.40) DNM1CES1CES2ALDH1A1CA1
SCHEMBL28030586 0.74 TSHR (0.47) ALDH1A1CA1CA12CA9TSHR
SCHEMBL11525191 0.74 PAM (0.49) DNM1DGKAALDH1A1LMNAPAM
SCHEMBL11529277 0.74 PAM (0.49) DNM1DGKAALDH1A1LMNAPAM
SCHEMBL27798814 0.73 ALDH1A1 (0.34) ALDH1A1CA1CA12CA9MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024105667-A1 FORMULATIONS FOR PREVENTING MOSQUITO BITES YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2024-05-23 WO claimed
WO-2024105667-A1 FORMULATIONS FOR PREVENTING MOSQUITO BITES YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2024-05-23 WO disclosed
US-20100330013-A1 AMADORIASES IN WASHING AND CLEANING PRODUCTS HENKEL AG & CO. KGAA (DE) 2010-12-30 US disclosed
US-7825268-B2 Alkoxylactones, alkoxylactams and alkoxythiolactams for controlling processes based on microbial interaction HENKEL AG & CO. KGAA (DE) 2010-11-02 US disclosed
EP-1337145-A4 ANHYDROUS INSECT REPELLENT COMPOSITION AVON PROD INC (US) 2009-05-27 EP disclosed
US-20080207734-A1 Novel alkoxylactones, alkoxylactams and alkoxythiolactams for controlling processes based on microbial interaction HENKEL AG & CO. KGAA (DE) 2008-08-28 US disclosed
US-7037515-B2 Anhydrous insect repellent composition AVON PRODUCTS INC. (US) 2006-05-02 US disclosed
US-20030191154-A1 Anhydrous insect repellent composition CITIBANK, N.A., LONDON BRANCH 2003-10-09 US disclosed
EP-1337145-A1 ANHYDROUS INSECT REPELLENT COMPOSITION AVON PRODUCTS, INC. (US) 2003-08-27 EP disclosed
WO-2002043489-A1 ANHYDROUS INSECT REPELLENT COMPOSITION AVON PRODUCTS, INC. (US) 2002-06-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080207734-A1 Novel alkoxylactones, alkoxylactams and alkoxythiolactams for controlling processes based on microbial interaction COASY, C1S, HACL2 DNM1 3424/4885CES1 546/4885DGKA 2766/4885
US-20030191154-A1 Anhydrous insect repellent composition CUTA, FAAH, ACHE DNM1 2212/4885CES1 2065/4885DGKA 2640/4885
US-20100330013-A1 AMADORIASES IN WASHING AND CLEANING PRODUCTS ALPI, POLR1C, ZAP70 DNM1 920/4885CES1 3119/4885DGKA 282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.